Related Experiment Video
Updated: May 31, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cholesterol lowering medication - patients' knowledge, attitudes and experiences.
Angela Gialamas1, Paul Aylward, Simon Vanlint
1School of Population Health and Clinical Practice, The University of Adelaide, South Australia, Australia. angela.gialamas@adelaide.edu.au
Australian Family Physician
|July 12, 2011
Summary
Many patients on cholesterol-lowering medication lack understanding of their condition and treatment. Improved patient education and self-management programs are desired to enhance adherence and outcomes.
Area of Science:
- Cardiology
- Patient Adherence
- Health Literacy
Background:
- Suboptimal patient adherence to cholesterol-lowering medication is a significant clinical challenge.
- Despite proven efficacy, patient compliance remains a barrier to managing hyperlipidaemia.
Purpose of the Study:
- To investigate patient knowledge, attitudes, and experiences with cholesterol-lowering medications.
- To explore patient perspectives on self-management support programs.
Main Methods:
- A semiqualitative exploratory study design.
- Semistructured telephone interviews were conducted with adult patients.
- Participants had poorly controlled hyperlipidaemia.
Main Results:
- Twenty-six patients were interviewed; most identified hyperlipidaemia risk factors.
- One-third did not understand why they took medication; over two-thirds misunderstood its mechanism.
- Patients desired more information and found general practitioners their primary source.
Conclusions:
- Patients on long-term statin therapy may exhibit knowledge gaps regarding their condition and treatment.
- A significant desire exists among patients for enhanced information and education.
- General practices could serve as effective venues for patient education initiatives.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...